REUN

Reunion Neuroscience Inc
1.31
0.05 (3.97%)

Reunion Neuroscience Inc. (REUN) Fundamentals

Field Trip is a global leader in the development and delivery of psychedelic therapies. With Field Trip Discovery, the company's research division, leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics, and its Field Trip Health division building centers for psychedelic therapies across North America and Europe along with the digital and technological tools that will enable massive scale.
SHARE INFORMATION
Market Cap$ 14,671,563
Shares Outstanding11,645,152
Float7,602,016
Percent Float65.29%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 3,887,651
Latest Fiscal EPS$ -3.80
Latest Fiscal Date2022-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions43
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months53,458
Institutional Holdings Percent16.2%
Institutional Sold Previous 3 Months299,399
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 9.75
52 Week Low$ 0.76
52 Week High Change$ -85.68
21 Day Moving Average$ 1.3517
21 Day Extended Moving Average$ 1.2931
50 Day Moving Average$ 1.2354
50 Day Extended Moving Average$ 1.3645
200 Day Moving Average$ 2.8943
200 Day Extended Moving Average$ 3.9327
10 Day Average Volume38,887
20 Day Average Volume66,258
30 Day Average Volume69,320
50 Day Average Volume46,078
Alpha-0.117732
Beta1.9507
Standard Deviation0.233652
R20.253806
7 Day Price Change$ -0.13
7 Day Percent Change-9.35%
21 Day Price Change$ -0.15
21 Day Percent Change-10.64%
30 Day Price Change$ 0.22
30 Day Percent Change21.15%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.36
Quarter to Date Percent Change40.0%
180 Day Price Change$ -2.96
180 Day Percent Change-70.15%
200 Day Price Change$ -2.99
200 Day Percent Change-70.35%
Year to Date Price Change$ 0.36
Year to Date Percent Change40.0%

Reunion Neuroscience Inc. (REUN) Key Ratios

PROFITABILITY
EBIT Margin-1,188.9%
EBITDA Margin-1,120.1%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin-7.8%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,406,715
Revenue Per Share$ 0.1208
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.10
Int Coverage-97.00
Current Ratio7.60
Leverage Ratio1.60
Quick Ratio7.00
Long Term Debt To Capital0.29
VALUATION MEASURES
PE Ratio-0.30
Enterprise Value$ -11,334,211
Price to Sales10.4306
Price to Free Cash-0.50
PE High Last 5 Years0.00
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.50
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-71.74
Return on Equity-90.45
Return on Capital-78.04

Reunion Neuroscience Inc. (REUN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOJoseph del Moral
Emplyoees194
Last AuditUQ
CIK0001865482
IndustryHealthcare Providers & Services
SectorHealthcare
NAICSOffices of Mental Health Practitioners (except Physicians)(621330)
CONTACT INFO
Address30 Duncan Street
Suite 401
Toronto, ON M5V 2C3
Websitehttps://www.fieldtriphealth.com
Facsimile+1 855 933-1211
Telephone+1 416 505-0929
Email-


Your Recent History
NASDAQ
REUN
Reunion Ne..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.